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a b s t r a c t
Aim: To study the prevalence of psychiatric comorbidities in patients of multiple sclerosis
and their association to the degree of disability.
Method: Psychiatric symptomswere assessed in 90 patients ofmultiple sclerosis using GHQ-
12, MMSE, HADS, Beck Depression Inventory and AUDIT. Neurological disability was
assessed using Expanded Disability Status Scale. Correlations were determined between
EDSS scores and psychiatric scale scores.
Result: 61% of patients had signiﬁcant psychological distress. Depressionwasmost common
(38.8%) which was followed by anxiety symptoms (27.8%). Cognitive functioning was
relatively intact in patients with mild to moderate neurological disability. Alcohol abuse
was mostly restricted to male gender.
Conclusion: Psychiatric illness is highly prevalent in patients of multiple sclerosis leading to
poor quality of life and signiﬁcant distress. Psychiatric disability was higher in patients who
had greater deterioration in neurological function. All cases of MS should be assessed for
psychiatric morbidities as can be alleviated by appropriate intervention.
© 2018 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.1. IntroductionMultiple sclerosis (MS) is an autoimmune condition causing
inﬂammatory demyelination of the central nervous system.
MS by affecting the adult in the prime of their productive life
exerts a considerable socioeconomic burden on society.
Psychiatric symptoms in MS are highly prevalent and
frequently overlooked in clinical settings [1]. Changes in
mood, personality, and cognitive functioning are among the
most disabling and distressing symptoms for individuals
diagnosedwithMS, yet patients and their families receive little
understanding or help with these problems [2]. Studies have* Corresponding author.
E-mail address: drsppanda@gmail.com (S.P. Panda).
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0028-3843/© 2018 Polish Neurological Society. Published by Elsevier Sshown that prevalence of psychiatric comorbidity is high even
at the time of MS diagnosis, and rises during the course of
disease. Further, depression, anxiety, and bipolar disorder
occur substantiallymore often in theMS population compared
to general population [3].
Although psychiatric manifestations are relatively com-
mon among patients with MS, there is paucity studies on
prevalence and impact of depression, anxiety, substance use,
cognitive impairment bipolar mood disorders/schizophrenia
in patients of MS. Keeping in view the above, this study was
undertaken in a tertiary care hospital of India. Though the
main objective is tomeasure the depression, anxiety, cognitive
disability and alcohol abuse, it is also intended to incorporatep. z o.o. All rights reserved.
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due to MS.2. Materials and methods
2.1. Sample and procedure
All consecutive diagnosed patients of Multiple sclerosis taking
treatment from Neurology Unit of our hospital consenting for
the studywere considered. The study received approval by the
Institutional Ethics Committee. A total of 90 patients were
assessed during the 18-month period. Most of the cases
interviewed were from neurology OPD (both old and new
cases). 20 patients were interviewed fromneurologyward. The
patientswere diagnosed as per 2010McDonald criteria (current
practiced guideline) [4] and greater than 18 years of age.
Patientswhodeclined to participate in the study,medically too
ill to participate, who were neither conversant in Hindi nor
English and psychotic patients were excluded. Patients
requiring psychiatric care were given option to seek consulta-
tion and detailed evaluation at psychiatric center which is co-
located.
2.2. Measures
All patients ﬁtting the inclusion criteria were assessed by
administration of the following questionnaires and scales:(a) Kurtzke Expanded Disability Status Scale (EDSS). It was used to
rate the degree of neurological disability. This scale is
considered the standard for quantifying disability in
patients with MS. Score range from 0–10 with higher
scores indicating more severe disability [5].
MS patients were divided into three groups based on
their EDSS scores:
i. Scoring 0–1.5 (with neurological symptoms but not
disabled)
ii. Scoring 2–4.5 (with neurological symptoms at disability
level but still fully ambulatory)
iii. Scoring 5.0–8.0 (in need of a cane, walker or wheelchair
due to lack of ambulation or wheelchair dependent)(b) Hindi version of General Health Questionnaire-12 (GHQ-12)
GHQ is a self-administered screening questionnaire
which has been widely used to detect non psychotic
psychiatric disturbances in a variety of settings [6].
Standardization of Hindi version of Goldberg's GHQ on
Indian population was done by Gautam et al. in 1987 [7].
Each item is rated on a four-point scale. A total score of 3 or
more was considered abnormal.(c) Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HADS) is a
14-item self-report screening scale that was originally
developed to indicate the possible presence of anxiety and
depressive states in the setting of a medical out-patient
clinic [8]. It contains two 7 item scales: one for anxiety and
one for depression both with a score range of 0–21. Each of
the items can be scored from 0 to 3 based on severity of
distress. A cut off score of ≥8 was ﬁxed for anxiety or
depression.(d) Beck Depression Inventory (BDI)
It is one of themostwidely used andwell-validated self-
report inventory to assess the intensity of depression in
psychiatric patients and for detecting possible depression
in normal populations. There are 21 groups of statements
which can be rated on a 4-point scale ranging from 0 to 3 in
terms of severity making maximum total score of 63 [9]. A
cut-off of 10 was ﬁxed for depression.(e) Mini-Mental State Examination (MMSE)
Since its introduction in 1975, MMSE has become a
widely used brief, standardized method to grade patients'
cognitive mental status. As per Folstein et al., any score
greater than or equal to 25 points (out of 30) indicates a
normal cognition. Score of 25 was taken as cut-off [10].(f) Alcohol Use Disorders Identiﬁcation Test (AUDIT)
The AUDIT was developed by the World Health
Organization (WHO) as a simple method of screening for
excessive drinking and to assist in brief assessment. There
is a total of 10 questions with score ranging from 0–40.
Based onWHOguidelines for use of AUDIT scoremore than
8 was taken as cut off [11].
2.3. Statistical analysis
Statistical analysis was carried out by using Statistical Package
for Social Sciences (SPSS) – 22. Our data has been analyzed
basically using categorical data. For each such character
frequencies and percentages have been computed. Therefore,
for testing for association we have used Chi square test based
on frequencies along with probability of signiﬁcance (Table 3).
For all statistical tests a p-value of 0.05 or less indicates
signiﬁcance (rejection of null hypothesis of agreement).
3. ResultsDuring the period of study, a total of 94 patients were
approached. 2 of them expressed unwillingness to participate
in the study. There were 2 dropouts who left the study during
the evaluation process.
In Table 1 shows count and percentage of discrete variables
age group, sex, type of MS, MMSE, GHQ-12, HADS-A, HADS-D,
BDI and AUDIT and EDSS categorized into various classes as
explained in methodology. In Table 2 descriptive statistics
with respect to all variables for which numerical values were
available are recorded. It shows the values of mean, Standard
deviation, Standard error ofmean,minimumandmaximumof
each variable.
Average age of all subjects was 38.07 years which ranged
from 18 to 65. Out of 90 patients, 54 patients were female and
36weremale. Incidentally there is only one patient in category
PP (primary progressive MS) and 6 patients in category SP
(Secondary progressive MS) as depicted in Table 1. The
maximum subjects were of category RR (Relapsing remitting
MS).
The average score in GHQ-12 came out to be 2.04 with SD of
1.52. 43 (47.78%) patients scored 3 or more which was taken as
cut off. On HADS, 25 patients (27.78%) had anxiety symptoms
whose scores lied above the cut off.When the datawas further
Table 1 – Tally: discrete variables: age group, sex, type of
MS, MMSE, GHQ-12, HADS-A, HADS-D, BDI, AUDIT and
EDSS.
Attribute Class Count Percent
Age group 18–28 19 21.10
29–39 34 37.78
40–49 24 26.67
50–65 13 14.44
Sex Male 36 40.00
Female 54 60.00
Type of MS RRMS 83 92.22
SPMS 6 6.67
PPMS 1 1.11
MMSE Abnormal 11 12.22
Normal 79 87.78
GHQ-12 Abnormal 55 61.11
Normal 35 38.89
HADS-A Abnormal 25 27.78
Normal 65 72.22
HADS-D Abnormal 32 35.96
Normal 58 64.04
BDI Abnormal 35 38.89
Normal 55 61.11
AUDIT Abnormal 14 15.56
Normal 76 84.44
EDSS Not disabled 18 20.00
Ambulatory 51 56.67
Not ambulatory 21 23.33
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patients had mild anxiety and 17 (18.9%) patients had
signiﬁcant anxiety. In present study HADS-A score of 11 or
more was signiﬁcant anxiety. On depression subscale of HADS
we found that out of total 90 subjects, 32 (35.96%) of patients
had signiﬁcant depressive symptoms. The ﬁndings from BDI
corroborated with the results obtained from HADS-D. 35
(38.89%) patients had scores above the cut off. Among 35
patients having signiﬁcant depressive symptoms, 11 patients
had mild level of depression (scores 11–16), 20 patients had
moderate level of depression (scores 17–29) and 4 patients had
severe level of depression (scores 30 and above).
MMSE, used to access the cognitive function, showed an
average score of 27.54 with SD of 2.19. 11 out of 90 patients
(12.22%) hadMMSE scores of 24 or belowwhichwas kept as cut
off. AUDIT clinical procedure showed 14 patients had
problematic alcohol use requiring further assessment and
possible intervention.
EDSS scores varied from a minimum of 1–7.5 with a mean
score of 3.45with SD of 1.683. In Table 1 as depicted, 18 patients
(20%) were not disabled or had minimal disability, 51 patientsTable 2 – Descriptive statistics: age, EDSS, MMSE, GHQ-12, HAD
Variable N Mean St dev
Age 90 38.070 10.470
EDSS 90 3.450 1.683
MMSE 90 27.544 2.194
GHQ-12 90 2.044 1.528
HADS-A 90 6.067 4.334
HADS-D 90 5.722 4.414
BDI 90 11.644 8.556
AUDIT 90 2.133 3.601(56.67%) were disabled but were ambulatory and 21 patients
(23.33%) were non-ambulatory.
There was strong association of EDSS with age of patients
( p = 0.0001). As age increased, the count of cases increases
from not disabled to disabled. However, there was no
signiﬁcant association between sex and EDSS (p = 0.562).
There was signiﬁcant association between type of MS and
EDSS scores. Subjects suffering from progressive MS had
higher EDSS scores compared to subjects of RRMS ( p = 0.03).
There was strong association between EDSS and MMSE
depicted by chi-square value of 8.06 with p = 0.018. As EDSS
score increased, there was deterioration of cognitive function
as reﬂected by decrease in MMSE scores.
Again, there was a strong association of GHQ-12 on EDSS
(chi-square value of 10.255, p = 0.006). It indicates that there is
increasing psychological distress in subjects with increasing
physical disability.
Chi-square analysis of EDSS with HADS-A shows that there
is an association between the 2 variables, but it failed to reach
statistical signiﬁcance (chi-square = 5.687, p = 0.058). There
was a statistically signiﬁcant association betweenHADS-Dand
EDSS (chi-square = 7.004with p = 0.03)meaning the depressive
symptomswas higher in patientswith high physical disability.
Similar signiﬁcant association was obtained between BDI and
EDSS (chi-square = 7.722 with p = 0.021). As physical disability
increased, there is also an increase in BDI scores.
Alcohol abuse in patients ofMS, accessedwithAUDIT, failed
to show any associationwith degree of disability. There was no
signiﬁcant association detected with age and AUDIT. However,
whenweanalyzed the effect of sex onAUDIT,we foundahighly
signiﬁcant association with chi-square value of 14.436 and
p = 0.0001. There were only 2 out of 54 females screened
positive for alcohol abuse compared to 12 out of 26 males.
4. DiscussionMultiple sclerosis is an autoimmune condition causing
inﬂammatory demyelination of the CNS. MS exerts a consid-
erable socioeconomic burden on society by affecting the adult
in the prime of their productive life. Psychiatric symptoms in
MS are highly prevalent and frequently overlooked in clinical
settings [1].
This study was a cross sectional descriptive study
incorporating diagnosed cases of multiple sclerosis as
per 2010 McDonald's criteria. In this study it was aimed to
detect the prevalence of psychiatric comorbidities in
patients of multiple sclerosis and their association to theS-A, HADS-D, BDI, AUDIT.
SE mean Minimum Maximum
1.100 18.000 65.000
0.177 1.000 7.500
0.231 21.000 30.000
0.161 0.000 6.000
0.457 0.000 16.000
0.465 0.000 17.000
0.902 2.000 37.000
0.380 0.000 14.000
Table 3 – Tests of association using Chi-square test.
Attribute Chi-square Degree of freedom P value
EDSS vs age 28.810 6 0.0001
EDSS vs sex 1.152 2 0.562
EDSS vs MS 10.676 4 0.030
EDSS vs MMSE 8.016 2 0.018
EDSS vs GHQ12 10.255 2 0.006
EDSS vs HADS-A 5.687 2 0.058
EDSS vs HADS-D 7.004 2 0.030
EDSS vs BDI 7.722 2 0.021
EDSS vs AUDIT 1.191 2 0.551
Age vs AUDIT 0.882 3 0.830
Sex vs AUDIT 14.436 1 0.0001
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Amato et al. in 1998 in a study on 106 patients found mean
age to be 44.89 with youngest patient aged 21 years and
oldest 69 years [12]. Sarisoy et al. in 2010 studied 79 patients of
MS in Turkey and reported mean age of patients to be
37.84 years [13]. A study conducted in India by Singhal et al.
reported mean age of the patients at the time of presentation
was 33.3  9.2 years [14].
In our study, majority of patients were female. Many
diseases with auto-immune etiology are known to have a
skewed sex distribution. Review of population studies reveals
that the preponderance of women in MS is almost constant.
In a large scale community survey by Chwastiak et al. on
719 patients found that 77.9% were females [15]. A study
conducted in Mangalore, India also shows a female prepon-
derance in which out of 35 patients, 22 were females [16]. The
skewed sex distribution inMS could be attributed to the known
hormonal and gender inﬂuences on the immune response, as
well as to genetic inﬂuences [17].
The relapsing remitting MS is themost common type of MS
worldwide comprising about 80% of cases [18]. Our result was
consistent with study by Karadayi et al. in 2014 in which MS
group composed of 90.3% RRMS [19].
Neurological disability as assessed by EDSS showed that
most of the patients (80%) had some formof signiﬁcant physical
disability. Physical disability was higher in patients who were
older and had progressive MS. These observations were
statistically signiﬁcant. A recent study done by Sarisoy et al.
has shown amean EDSS score of 2.58 [13]. A study conducted at
NIMHANS, Bangalore on 31 patients showed mean EDSS score
to be 3.5 [20]. There was very strong association between EDSS
and age. As age increased, the count of cases increases fromnot
disabled to disabled. This is akin to the study done by
Chwastiak et al. in 2005 which has shown as duration of
illness increases, there is an increase in the disability [15].
Psychiatric disorders seem to have profound effects on
wide-ranging aspects of the lives of personswho haveMS. The
prevalence of psychiatric comorbidity is high even at the time
of MS diagnosis, and rises over the course of the disease. In
present study, we attempted to assess common psychiatric
comorbidities.
12.22% of patients had impaired cognitive function.
Patients with greater physical disability had poor cognitive
functioning which was reﬂected by decrease in MMSE scores
with increase in EDSS scores (p = 0.018). This is in concurrence
with previous studies where it found that EDSSwas signiﬁcantpredictor of cognitive deﬁcits. The results were akin to the
results from a study by Amato et al. in sample of 103 patients.
The study found an average MMSE score was 27.26 with SD of
2.78 [12]. Another study from Turkey by Karadayi et al.
assessed cognitive function on 31 patients of MS using MMSE,
showed mean score to be 28.29. The study also showed
signiﬁcant impairment in selective attention, cognitive ﬂexi-
bility and processing speed compared to controls which was
measured by stroop test. [19]. Considering all previous studies,
the percentage of subjects screened positive for cognitive
impairment varied depending on screening tool used and
characteristics of subjects, however all studies have shown
signiﬁcant impairment in cognitive function in patients of MS
irrespective of methodology used.
A clear majority of patients (47.78%) had some form of
psychological distress which was reﬂected by GHQ-12. Also,
we found in our study that distress increased with increasing
physical disability (p = .006). Lincoln et al. screened 311
patients of MS in 2011 at Nottingham, UK on GHQ-12, out of
which 221 (71%) had signiﬁcant amount of distress [21].
27.78% of patients had signiﬁcant anxiety symptoms on
HADS screening tool. The association with EDSS and HADS-A
was near signiﬁcant (p = 0.058). We found that that in young
people with less physical disability, anxiety was comparatively
higher to subjects who were not ambulatory. This is consistent
with the study of Da Silva et al., where they reported 26.6% of
patients were having signiﬁcant anxiety [22]. In contrast to the
present study, Watson et al in a study conducted at United
Kingdom reportedhigh levels of anxiety inwhich 47% (n = 34) of
subjects had scores more than 7 on HADS-A [23]. Korostil et al.
took score of 10 on HADS as cut off and found prevalence of
anxiety disorders to be 14% [24]. Depending on method of
assessment used and sample population, prevalence of anxiety
varied across studies. Considering all studies, the prevalence of
diagnosed anxiety ranged from 1.24% to 36% [22,25,26].
A substantial number of subjects had prominent depressive
symptoms and as physical disability increased, there was also
an increase in the depressive symptoms which was reﬂected
by statistically signiﬁcant association between HADS-D and
BDI with EDSS (p = 0.03 and 0.021) respectively. This ﬁnding
agrees with studies in the literature scanning depressive
symptoms in MS patients. Depressive symptoms were more
prevalent in the progressive-course MS group in our study.
Since progressive MS is a more severe form of the disease, this
is an expected ﬁnding. Watson et al in a study conducted at
United Kingdom reported high levels of depression in which
50% (n = 34) of subjects had scoresmore than 7 onHADS-D [23].
Da Silva et al. studied 325 patients of MS in Portugal and
measured depression using HADS. They reported 30.4% of
patients were having signiﬁcant depression [22]. Saadat et al.
in a population-based study of 160 subjects conducted in Iran
measured depression using BDI. They have reported 69.4%
were having depressive symptoms [27]. Mattioli et al. demon-
strated the prevalence of depressive symptoms to be 25% in a
sample of Italian MS patients, which was lower than what we
actually found [28]. This difference in results might be due to
the use of various diagnostic or screening tools for the
detection of depression, or the use of different cut-off points
for screen tools. Other possible explanations for this could be
related to study design or population sampling.
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abuse was signiﬁcantly higher inmale gender (p = 0.0001). This
is in correlation with similar studies conducted earlier which
has shown that men endorsed higher rate of alcohol use than
women. It can also be inferred that the alcohol abuse is lower in
women than in men in the community from where these
subjects were taken. Bombardier et al. in 2003 surveyed 1374
persons with MS and found 14% screened positive for possible
alcohol abuse or dependence. Alcohol abuse was associated
with younger age and less severe MS related disability [29].
Turner et al. used the AUDIT for their study and reported that
13.9% of their veteran population of MS individualsmet criteria
for excessive drinking. One possible explanation for thisﬁnding
is the sampled population. It was noted in the literature that
excessive drinkers tend to be younger, employed and less
disabled than their non-drinking peers [30].
The strengths of the study were a large sample size
considering the prevalence of multiple sclerosis. Only the
patients satisfyingwell-deﬁned diagnostic criteria formultiple
sclerosis were taken. The scales used to screen for psychiatric
disability were validated for the study population. This study
had several limitations. As with any other cross-sectional
study, our study lacked temporality for determining causal
associations. Recall bias and reporting bias cannot be excluded
as most of the questionnaires are self-reporting. The ﬁndings
of the study can only be extrapolated to hospital patients.
Patients with low MMSE scores received help for completing
othermeasurements. Also, patients not conversant with Hindi
received help in completing GHQ. Data related to immediate
reason for hospitalization or seeking outpatient care was not
collected. The association of relapses affecting EDSS scores
cannot be ascertained from present study.
5. ConclusionsFrom the study it can be reasonably concluded that psychiatric
illness is highly prevalent in patients of multiple sclerosis
leading to poor quality of life and signiﬁcant distress.
Depression is the common symptom which is followed by
anxiety. A modest number of patients had poor cognitive
function and alcohol abuse were mostly restricted to male
gender. We can also conclude that psychiatric disability was
higher in patients who had greater deterioration in neurologi-
cal function. All cases of MS should be assessed for psychiatric
morbidities. Psychiatric morbidity increases distress in
patients of MS and worsens the quality of life. This can be
alleviated by appropriate intervention.
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